Ethic Inc.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1780570 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$683,393

+$92,891 QoQ

Shares Held

20,171

+2.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#368

of 676 holders

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

Ethic Inc. holds $15,329,079 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	365,253	$5,855,005
2	ZTS	Zoetis Inc.	40,796	$2,931,600
3	RDY	Dr Reddys Laboratories Ltd	132,074	$1,913,752
4	HLN	Haleon plc	109,770	$1,024,154
5	VTRS	Viatris Inc	53,626	$851,580
6	UTHR	UNITED THERAPEUTICS Corp	1,539	$833,876
7	ELAN	Elanco Animal Health Inc	33,453	$823,278
8	TEVA	Teva Pharmaceutical Industries Ltd This page	20,171	$683,393

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$683,393	20,171	+2.9%	Shares	Sole	2026-07-29
2026-03-31	$590,502	19,605	+8.2%	Shares	Sole	2026-04-27
2025-12-31	$565,743	18,127	+1.8%	Shares	Sole	2026-02-03
2025-09-30	$359,600	17,802	-3.7%	Shares	Sole	2025-10-17
2025-06-30	$309,892	18,490	-7.0%	Shares	Sole	2025-07-30
2025-03-31	$305,693	19,889	-64.0%	Shares	Sole	2025-05-13
2024-12-31	$1,219,318	55,323	+45.4%	Shares	Sole	2025-02-14
2024-09-30	$685,769	38,056	-14.2%	Shares	Sole	2024-11-13
2024-06-30	$721,110	44,376	+11.0%	Shares	Sole	2024-08-13
2024-03-31	$564,103	39,979	+256.0%	Shares	Sole	2024-05-13
2023-12-31	$117,251	11,231	-1.5%	Shares	Sole	2024-02-14
2023-09-30	$116,351	11,407	-21.0%	Shares	Sole	2023-11-14
2023-03-31	$127,847	14,446	+7.9%	Shares	Sole	2023-05-12
2022-09-30	$108,073	13,392	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.